Status:
COMPLETED
Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy
Lead Sponsor:
Lokman Hekim University
Conditions:
Duchenne Muscular Dystrophy
Eligibility:
All Genders
5-26 years
Phase:
NA
Brief Summary
Duchenne Muscular Dystrophy (DMD) is a progressive genetic neuromuscular disease characterized by progressive loss of motor function, respiratory failure, and cardiomyopathy required regular physiothe...
Eligibility Criteria
Inclusion
- Able to communicate verbally and visually,
- Older than 5 years old
Exclusion
- Individuals who had undergone any surgical operations in the past 6 months,
- Had a severe cognitive and breathing impairment,
- Using mechanical ventilator continually or intermittent,
- Having febrile infection
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT06103006
Start Date
January 1 2021
End Date
February 10 2022
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lokman Hekim University
Ankara, Turkey (Türkiye)